{"id":"slow-infusion-of-rubidium-82","safety":{"commonSideEffects":[{"rate":null,"effect":"Flushing"},{"rate":null,"effect":"Chest discomfort"},{"rate":null,"effect":"Dyspnea"},{"rate":null,"effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL1200727","moleculeType":"Small molecule","molecularWeight":"117.37"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Rubidium-82 is a potassium analog that is taken up by viable myocardial cells via Na+/K+-ATPase pumps. When infused slowly intravenously, it distributes to the heart in proportion to regional blood flow. The positron emissions are detected by PET cameras to create images showing areas of reduced perfusion (ischemia) versus normal perfusion, enabling assessment of coronary artery disease and myocardial viability.","oneSentence":"Rubidium-82 is a positron-emitting radioactive tracer that accumulates in myocardial tissue proportional to blood flow, allowing visualization of cardiac perfusion defects via PET imaging.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:08:21.231Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Myocardial perfusion imaging for detection of coronary artery disease"},{"name":"Assessment of myocardial viability in patients with coronary artery disease"}]},"trialDetails":[{"nctId":"NCT05286593","phase":"PHASE4","title":"3D PET Myocardial Blood Flow and Rb82 Infusion Profiles","status":"COMPLETED","sponsor":"Ochsner Health System","startDate":"2021-12-28","conditions":"Normal Healthy Volunteers Without Chronic Medical Conditions, Coronary Artery Disease, Cardiac Risk Factors","enrollment":98}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["20 mls/min of Rubidium-82"],"phase":"marketed","status":"active","brandName":"Slow Infusion of Rubidium-82","genericName":"Slow Infusion of Rubidium-82","companyName":"Ochsner Health System","companyId":"ochsner-health-system","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Rubidium-82 is a positron-emitting radioactive tracer that accumulates in myocardial tissue proportional to blood flow, allowing visualization of cardiac perfusion defects via PET imaging. Used for Myocardial perfusion imaging for detection of coronary artery disease, Assessment of myocardial viability in patients with coronary artery disease.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}